文献速递腹部CT

基于CT的影像组学列线图:无肝硬化肝脏中鉴别肝细胞腺瘤与肝细胞癌的潜在工具

CT-Based Radiomics Nomogram: A Potential Tool for Differentiating Hepatocellular Adenoma From Hepatocellular Carcinoma in the Noncirrhotic Liver.
PubMed 文献 · Acad Radiol · 2020-05-05

本研究纳入131例无肝硬化肝脏患者(肝细胞腺瘤46例、肝细胞癌85例),分为训练集93例和测试集38例,基于三期增强CT提取影像组学特征构建列线图,联合影像组学评分与独立临床因素。训练集中列线图AUC为0.96(95%CI 0.93-0.99),测试集中AUC为0.94(95%CI 0.87-1.00),决策曲线分析显示列线图临床实用性优于临床因素模型和影像组学特征。结论提示基于CT的影像组学列线图有潜力准确鉴别无肝硬化肝脏中的肝细胞腺瘤与肝细胞癌。

要点

  • 性别、年龄和强化方式是鉴别肝细胞腺瘤与肝细胞癌的独立临床因素。
  • 列线图在训练集和测试集的AUC分别为0.96和0.94,决策曲线分析显示其临床实用性优于临床因素模型和影像组学特征。

关键影像表现/征象

  • 性别、年龄和强化方式是鉴别肝细胞腺瘤与肝细胞癌的独立临床因素。

诊断标准与关键数值

  • 训练集中,影像组学列线图AUC为0.96(95%CI 0.93-0.99),临床因素模型AUC为0.93(95%CI 0.88-0.99),影像组学特征AUC为0.83(95%CI 0.74-0.92);列线图和临床因素模型的区分能力优于影像组学特征(P值分别为0.001和0.047)。
  • 测试集中,影像组学列线图AUC为0.94(95%CI 0.87-1.00),影像组学特征AUC为0.75(95%CI 0.59-0.91);列线图区分能力优于影像组学特征(P=0.013)。
  • 决策曲线分析显示,影像组学列线图在临床实用性方面优于临床因素模型和影像组学特征。

临床应用与阅片要点

  • 作者认为基于CT的影像组学列线图有潜力准确鉴别无肝硬化肝脏中的肝细胞腺瘤与肝细胞癌。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To evaluate the value of a radiomics nomogram for preoperative differentiating hepatocellular adenoma (HCA) from hepatocellular carcinoma (HCC) in the noncirrhotic liver.

MATERIALS AND METHODS: One hundred and thirty-one patients with HCA (n = 46) and HCC (n = 85) were divided into a training set (n = 93) and a test set (n = 38). Clinical data and CT findings were analyzed. Radiomics features were extracted from the triphasic contrast CT images. A radiomics signature was constructed with the least absolute shrinkage and selection operator algorithm and a radiomics score was calculated. Combined with the radiomics score and independent clinical factors, a radiomics nomogram was developed by multivariate logistic regression analysis. The performance of the radiomics nomogram was assessed by calibration, discrimination and clinical usefulness.

RESULTS: Gender, age, and enhancement pattern were the independent clinical factors. Three thousand seven hundred and sixty-eight features were extracted and reduced to 7 features as the optimal discriminators to build the radiomics signature. The radiomics nomogram (area under the curve [AUC], 0.96; 95% confidence interval [CI], 0.93-0.99) and the clinical factors model (AUC, 0.93; 95%CI, 0.88-0.99) showed better discrimination capability (p = 0.001 and 0.047) than the radiomics signature (AUC, 0.83; 95%CI, 0.74-0.92) in the training set. In the test set, the radiomics nomogram (AUC, 0.94; 95%CI, 0.87-1.00) performed better (p = 0.013) than the radiomics signature (AUC, 0.75; 95%CI, 0.59-0.91). Decision curve analysis showed the radiomics nomogram outperformed the clinical factors model and the radiomics signature in terms of clinical usefulness.

CONCLUSION: The CT-based radiomics nomogram has the potential to accurately differentiate HCA from HCC in the noncirrhotic liver.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Nie P, Wang N, Pang J, et al. CT-Based Radiomics Nomogram: A Potential Tool for Differentiating Hepatocellular Adenoma From Hepatocellular Carcinoma in the Noncirrhotic Liver. Acad Radiol. 2020. PMID: 32386828. doi:10.1016/j.acra.2020.04.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。